logo
Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137
rus
русский
eng
english

Site search



Correspondence address
310 Mira Street, Stavropol, Russia, 355017

Tel
+7 8652 352524; +7 8652 353229.

Fax
+7 8652 352524.

E-mail
medvestnik@stgmu.ru

Methidical approaches to bioassay of phenolic hydroxylenes contain substances

[Experimental medicine]
Alexander Khokhlov; Ilya Yaichkov; Yuriy Dzhurko; Leonid Shitov;

This article describes method of development approaches for bioassay of substances containing stable and unstable phenolic hydroxyls using methyldopa and mycophenolic acid for example

Download

References:
1. On the Approval of the Rules for Conducting Bioequivalence Studies of Medicinal Products within the Eurasian Economic Union: Decision of the Council of the Eurasian Economic Commission of November 3, 2016. № 85.
2. Tukavkina N. A., ed. Organic chemistry. Book 1: Basic course. Мoscow: Drofa, 2003.
3. Mironov A. N., ed. Manual on expertise of medicines. V. I. Moscow: Grif i K, 2013.
4. Khokhlov A. L., Shitov L. N., Dzhurko Y. A. [et al.] Quantitative determination of mycophenolic acid in human plasma by liquid chromatography – tandem mass spectrometry. Pharm. Chem. J. 2017; 51(6): 58-61.
5. Benoit-Biancamano M.-O., Caron P., Levesque E. [et al.] Sensitive high-performance liquid chromatography–tandem massspectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. J. Chromatogr B. 2007; 858: 159–167. doi:10.1016/j.jchromb.2007.08.023
6. Brandhorst G., Streit F., Goetze S. [et al.] Quantification by Liquid Chromatography Tandem Mass Spectrometry of Mycophenolic Acid and Its Phenol and Acyl Glucuronide Metabolites. Clin. Chem. 2006;52(10):1962-1964. doi: 10.1373/clinchem.2006.074336
7. Buchwald A., Winkler K., Epting T. [et al.] Validation of an LC–MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA. BMC Clin. Pharm. 2012;12:1-11. doi: 10.1186/1472-6904-12-2
8. Delavenne X., Juthier L., Pons B. [et al.] UPLC–MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic study. Clin. Chim. Act. 2011;412:59-65. doi:10.1016/j.cca.2010.09.041
9. Elbarty F. A., Shoke A. S. Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: Pharmacokinetic application. J. Chromatogr. B. 2007;859:276-281. doi:10.1016/j.jchromb.2007.09.036
10. Guideline on validation of bioanalytical methods (draft): European Medicines Agency, Committee for medicinal products for human use, 2013.
11. Heinig K., Bucheli F., Hartenbach R. [et al.] Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots. Bioanal. 2010;8(2):1423-1435. doi: 10.4155/bio.10.99
12. Li W., Zhang J., Tse F. L. S. Handbook of LC-MS Bioanalysis. New Jersey: Jonh Wiley and Sons, 2013.
13. Maddela R., Pilli N. R., Maddela S. A novel and Rapid LC–MS/MS assay for the Determination of Mycophenolate and Mycophenolic Acid in Human Plasma. J. Young Pharm. 2017; 9 (1):107-114. doi: 10.5530/jyp.2017.9.20
14. Oliveira C. H., Barrientos-Astigarraga R. E., Sucupira M. [et al.] Quantification of methyldopa in human plasma by high-performance liquid chromatography–electrospray tandem mass spectrometry. Application to a bioequivalence study. J. Chromatogr. B. 2002;768(2): 341-348. doi: 10.1016/S1570-0232(01)00612-2
15. Rebollo N., Calvo M. V., Martin-Saurez A. [et al.] Modification of the EMIT immunoassay for the measurement of unbound mycophenolic acid in plasma. Clin. Biochem. 2011;44:260-263. doi: 10.1016/j.clinbiochem.2010.09.025
16. Róna K., Ary K., Renczes G. [et al.] Comparative Bioavailability of Alpha-Methyldopa normal and film tablet formulations after single oral administration in healthy volunteers. Eur. J. Drug Metab. and Pharmacok. 2001;26(1-2):25-30.
17. Valizadeh H., Nemati M., Hallaj-Nezhadi S. [et al.] Single dose bioequivalence study of a-methyldopa tablet formulations using a modified HPLC method. Arzn. 2010;60(10):607-611. doi: 10.1055/s-0031-1296333
18. Van de Merbel N. C., Hendriks G., Imbos R. [et al.] Quantitative determination of free and total dopamine in human plasma by LC-MS/MS: the importance of sample preparation. Bioanal. 2011;17(3):1949-1961. doi: 10.4155/bio.11.170
19. Vlase L., Mihu D., Popa D.-S. Determination of methyldopa in human plasma by LC/MS-MS for therapeutic drug monitoring. Stud. Univ. Babes-Bolyai Chem. 2013;58(1):31-41.
20. Upadhuaya V., Trivedy V., Shah G. [et al.] Determination of mycophenolic acid in human plasma by ultra performance liquid chromatography tandem mass spectrometry. J. Pharm. Anal. 2014;4(3):205-216. doi: 10.1016/j.jpha.2013.06.001
21. Wang L., Qiang W., Li Y. [et al.] A novel freeze-dried storage and preparation method for the determination of mycophenolic acid in plasma by high-performance liquid chromatography. Biomed. Chromatogr. 2017;31(5):3-27. doi:10.1002/bmc.3958
22. Wiesen M. H. J., Farowski F., Feldkötter M. [et al.] Liquid chromatography–tandem mass spectrometry method for the quantification of mycophenolic acid and its phenolic glucuronide in saliva and plasma using a standardized saliva collection device. J. Chromatogr. A. 2012;1241:52-59. doi: 10.1016/j.chroma.2012.04.008

Keywords: phenolic hydroxyls, bioassay, mycophenolic acid, methyldopa, stabilization


Founders:
Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy